Most Recent Posts
At the Newseum last night, here in Washington, I was privileged to be part of an event honoring some truly inspiring and remarkable people.
Below is a guest blog post from Chris deVries, the Chief Executive Officer/Executive Vice-President of the American Association for Geriatric Psychiatry (AAGP). AAGP is a national association representing and serving its members and the field of geriatric psychiatry and promotes the mental health and well-being of older people.
In a blog post today, Pharmalot delves into various opinions on biopharmaceutical research and development (R&D) spending.
Today we're featuring a blog post from Val Halamandaris, the President of the National Association for Home Care and Hospice (NAHC).
With the start of the next round of negotiations for the Trans Pacific Partnership in Leesburg, Virginia many Americans probably do not know how important these talks are to U.S. jobs and exports. The biopharmaceutical sector directly employed more than 650,000 U.S. workers in 2009, supporting a total of 4 million jobs [in areas such as construction, trucking, and information technology.
The clock is ticking as we count down the remaining days until the first ever Research and Hope Award ceremony, where we will have the privilege of honoring individuals who have made incredible sacrifices in the great battle against Alz
Ten thousand baby boomers will turn 65 today. This will happen again tomorrow, the next day and every day until 2030. With such a significant growth in Medicare eligible Americans, ensuring effective coverage and access to medicines well into the future is a priority.
A strong U.S. biopharma industry is vital to ensuring the health of our nation's economy and citizens. Investment in R&D supports jobs within a variety of U.S. industries. The below infographic explains how only with a strong and growing biopharma sector can we add jobs, reduce long term healthcare costs and prolong the quality of life for all Americans.